Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Redington
Recent news which mentions Redington
Precigen's Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy
December 08, 2022
Tickers
ALLO
BMY
CRBU
CRSP
Tags
GILD
Partner Content
Redington
From
Benzinga
KOL Webinar on Genetic Blindness Points to Promise of Kiora's Pioneering Solution--Clinical Data in Q1
October 27, 2022
Tickers
KPRX
Tags
Market News
Redington
Benzinga
From
Benzinga
Kiora Pharma is Starting Human Trials of a Novel Treatment That Could Restore Vision In Patients With Inherited Blindness
September 29, 2022
Tickers
FDMT
KPRX
MGTX
VANI
Tags
Redington
VANI
General
From
Benzinga
At Tonix, History Underpins a Modern Approach to COVID-19 Vaccines
May 05, 2022
Tickers
TNXP
Tags
Partner Content
Penny Stocks
Biotech
From
Benzinga
Regulus Moving Closer To Potential $25 Million Milestone Payment For Novel Kidney Disease Treatment Licensed To Sanofi
March 18, 2022
Tickers
RETA
RGLS
SNY
Tags
SNY
Biotech
RETA
From
Benzinga
Could This Be A Potential New Weapon In The Fight Against COVID-19?
February 01, 2022
Tickers
BNTX
MRNA
PFE
TNXP
Tags
Market News
PFE
MRNA
From
Benzinga
New Study Comparing Plant-Derived and Synthetic CBD Efficacy Opens Door to Exciting Medical Uses of Cannabidiol
September 23, 2021
Tickers
ARTL
Tags
Benzinga
General
Redington
From
Benzinga
For COVID-19, Live Virus Vaccines Could Give Longer Term Protection Than the Current Warp Speed Vaccines — But They're Not Here Yet
September 14, 2021
Tags
Benzinga
Health Care
General
From
Benzinga
More Than Vaccines: Tonix Programs Address the Spectrum of Covid-19 Problems from Prevention, to Infection to Post-Viral Syndrome
July 15, 2021
Tickers
JNJ
PFE
Tags
Redington
Benzinga
General
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.